EFX vs TMDX · P/E 54, rev $3.35B vs P/E 17, rev $363.9M
Equifax Inc (EFX) versus TransMedics Group Inc (TMDX) — a side-by-side from cached financials, not a winner call.
Equifax Inc (EFX) is a consulting services company listed on US.
TransMedics Group Inc (TMDX) is a medical devices company listed on NASDAQ.
Latest reported EFX revenue for 2026-06-30 was $3.35B. Net income was $355.4M. EFX currently screens at market cap $33.00B and trailing P/E 54.0.
Latest reported TMDX revenue for 2026-06-30 was $363.9M. Net income was $22.0M. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
EFX currently screens at market cap $33.00B and trailing P/E 54.0. TMDX currently screens at market cap $2.53B and trailing P/E 16.8.
Not investment advice. Open the EFX and TMDX stock pages for the full models.
Not investment advice.